Four Diabetes Drugs Included in Medicare Price Negotiation List

In September, the federal government unveiled a list of the first 10 drugs that will undergo price negotiations between Medicare and pharmaceutical companies. Notably, four of these drugs are diabetes medications.

New prices for these medicines will be announced in September 2024 and new prices will take effect on January 1, 2026, unless pharmaceutical companies challenging the law in court prevail.

This negotiation list is the result of the Inflation Reduction Act, which President Biden enacted last year. This law included a provision requiring the government to begin negotiating a fair market price for widely used drugs. The Endocrine Society worked with Congress and the administration to pass this law, and we have since advocated for insulin inclusion on the negotiation list.

The Inflation Reduction Act included other provisions that would improve insulin affordability for Medicare beneficiaries, including a $35 monthly cap on insulin costs. However, insulin remains unaffordable to the millions of people with diabetes who have private insurance.

The Endocrine Society continues to urge Congress to pass legislation that will address insulin affordability for these patients. You can see our position statement for further information.

You may also like

  • Endocrine Society Continues to Advocate for Insulin Affordability

    The Endocrine Society continues to advocate for insulin affordability. Although new legislation to make insulin more affordable has been stalled in Congress, the Centers for Medicare and Medicaid Services (CMS) continues to advance a program to implement drug price negotiations to lower the cost of certain prescription drugs, including several diabetes medications. CMS recently hosted…

  • Head Start: Endocrinology Mentor Day Debuts at ENDO 2023

    The brainchild of the Endocrine Society’s Clinical Affairs Core Committee to ensure the pipeline of future endocrinologists keeps flowing, Endocrinology Mentor Day launched in Chicago during ENDO 2023. “There are a few things I like about endocrinology,” says Marah Alsayed Hasan, MD, an internal medicine resident at Lankenau Hospital in Wynnewood, Pa. “It’s a very…

Find more in